587 related articles for article (PubMed ID: 33500564)
1. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes.
Sencio V; Machado MG; Trottein F
Mucosal Immunol; 2021 Mar; 14(2):296-304. PubMed ID: 33500564
[TBL] [Abstract][Full Text] [Related]
2. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between immune system and microbiota in COVID-19.
Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
5. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
6. Possible role of gut microbes and host's immune response in gut-lung homeostasis.
Rastogi S; Mohanty S; Sharma S; Tripathi P
Front Immunol; 2022; 13():954339. PubMed ID: 36275735
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters.
Sencio V; Benech N; Robil C; Deruyter L; Heumel S; Machelart A; Sulpice T; Lamazière A; Grangette C; Briand F; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2100200. PubMed ID: 35830432
[TBL] [Abstract][Full Text] [Related]
8. Emerging pathogenic links between microbiota and the gut-lung axis.
Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
[TBL] [Abstract][Full Text] [Related]
9. Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota.
Groves HT; Cuthbertson L; James P; Moffatt MF; Cox MJ; Tregoning JS
Front Immunol; 2018; 9():182. PubMed ID: 29483910
[TBL] [Abstract][Full Text] [Related]
10. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia.
Hanada S; Pirzadeh M; Carver KY; Deng JC
Front Immunol; 2018; 9():2640. PubMed ID: 30505304
[TBL] [Abstract][Full Text] [Related]
11. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 and the gut-lung axis.
Zhou D; Wang Q; Liu H
Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
[TBL] [Abstract][Full Text] [Related]
13. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.
Hussain I; Cher GLY; Abid MA; Abid MB
Front Immunol; 2021; 12():765965. PubMed ID: 34721437
[TBL] [Abstract][Full Text] [Related]
14. Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair.
Marrella V; Nicchiotti F; Cassani B
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612860
[TBL] [Abstract][Full Text] [Related]
15. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
16. Probiotics as a biotherapeutics for the management and prevention of respiratory tract diseases.
Debnath N; Kumar A; Yadav AK
Microbiol Immunol; 2022 Jun; 66(6):277-291. PubMed ID: 35462444
[TBL] [Abstract][Full Text] [Related]
17. Microbial and Immune Regulation of the Gut-Lung Axis during Viral-Bacterial Coinfection.
Lane S; Hilliam Y; Bomberger JM
J Bacteriol; 2023 Jan; 205(1):e0029522. PubMed ID: 36409130
[TBL] [Abstract][Full Text] [Related]
18. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
[TBL] [Abstract][Full Text] [Related]
19. Viral Infections, the Microbiome, and Probiotics.
Harper A; Vijayakumar V; Ouwehand AC; Ter Haar J; Obis D; Espadaler J; Binda S; Desiraju S; Day R
Front Cell Infect Microbiol; 2020; 10():596166. PubMed ID: 33643929
[TBL] [Abstract][Full Text] [Related]
20. Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production.
Sencio V; Barthelemy A; Tavares LP; Machado MG; Soulard D; Cuinat C; Queiroz-Junior CM; Noordine ML; Salomé-Desnoulez S; Deryuter L; Foligné B; Wahl C; Frisch B; Vieira AT; Paget C; Milligan G; Ulven T; Wolowczuk I; Faveeuw C; Le Goffic R; Thomas M; Ferreira S; Teixeira MM; Trottein F
Cell Rep; 2020 Mar; 30(9):2934-2947.e6. PubMed ID: 32130898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
